Skip to content

Age and Insulin Resistance

In French AGIR Means to Get Into Action. This is the Generic Title of Our Study.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01224886
Acronym
AGIR
Enrollment
150
Registered
2010-10-20
Start date
2010-10-31
Completion date
2028-12-31
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Obesity, Physical Inactivity

Keywords

Aging, Insulin resistance, Ectopic lipids, Obesity, Exercise, Physical activity, Oxidative capacity, Diabetes, Metabolic syndrome

Brief summary

Insulin resistance is a crucial factor for the development of type 2 diabetes and a major health problem for older adults. It is the principal mechanism by which obesity is considered to increase the risk for type 2 diabetes and is a key feature of the metabolic syndrome. The elevated prevalence of obesity and type 2 diabetes in the older population has important consequences on the morbidity and mortality as well as on the economic burden on society. Controversy currently exists as to whether or not aging contributes to insulin resistance. Many potential factors confound the association between aging and insulin resistance, including obesity and physical inactivity. Ectopic lipid depositions, defined as an excess accumulation of triglycerides in non adipose tissues such as in the liver (intrahepatic lipids) and within the muscle fibers (intramyocellular lipids), are positively associated with obesity and insulin resistance. Furthermore, the accumulation of intracellular lipids is often cited as being a key determinant in the underlying mechanisms of insulin resistance. In addition of playing an important role in obesity and type 2 diabetes, these ectopic fat depositions are also observed in common conditions such as aging and physical inactivity. The intervention trial will test in skeletal muscle, liver and heart of sedentary obese volunteers, normal weight volunteers and masters athletes, the overall hypotheses that exercise improvement of fat oxidation capacity and/or decrease of damaging fat metabolites is a primary factor that predicts the improvement in insulin resistance.

Interventions

BEHAVIORALPhysical activity

Supervised exercise intervention

Sponsors

Centre Hospitalier Universitaire Vaudois
CollaboratorOTHER
University of Lausanne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 60-80 * Sedentary or highly trained * BMI 18-40 * Non-Smoker * Normal glucose tolerance or impaired glucose tolerance * Willingness to comply with the protocol

Exclusion criteria

* Contraindication to moderate exercise or clinical conditions precluding from joining an exercise program, such as clinically significant cardiovascular disease, peripheral vascular disease, uncontrolled hypertension, neurological or orthopedic disease * Recent weight loss or weight gain * Known diabetes * Known drugs to affect glucose homeostasis such as nicotinic acid, glucocorticoids * Severe anemia or lipid disturbances, hepatic or renal disease * Recent history of cancer * Hypothyroidism * Recent hormone replacement therapy * Known allergy to lidocaine or other local anesthetic * Positive stress test * Active alcohol or substance abuse

Design outcomes

Primary

MeasureTime frame
Insulin sensitivity0-4 months
Ectopic lipids0-4 months
Oxidative capacity0-4 months

Secondary

MeasureTime frame
Exercise efficiency0-4 months
Metabolic flexibility0-4 months
Physical fitness0-4 months
Body composition0-4 months

Countries

Switzerland

Contacts

Primary ContactFrancesca Amati, MD, PhD
francesca.amati@unil.ch+41 21 692 5552

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026